Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.913
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $20.4 million as of January 2, 2026. Its market cap has decreased by -53.79% in one year.
Market Cap
20.40M
Enterprise Value
15.17M
1-Year Change
-53.79%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $20.40M, a decrease of -83.70%. That is a compound annual growth rate of -64.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |